{
    "Trade/Device Name(s)": [
        "Remel Spectra ESBL",
        "Remel Spectra\u2122 ESBL",
        "Chromogenic ESBL",
        "Spectra\u2122 ESBL"
    ],
    "Submitter Information": "Remel, Inc.",
    "510(k) Number": "K162620",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160512"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JSO"
    ],
    "Summary Letter Date": "March 29, 2017",
    "Summary Letter Received Date": "March 30, 2017",
    "Submission Date": "April 28, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.1700"
    ],
    "Regulation Name(s)": [
        "Culture medium for antimicrobial susceptibility tests"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Extended Spectrum Beta Lactamase (ESBL)-producing Escherichia coli",
        "Klebsiella pneumoniae",
        "Klebsiella oxytoca",
        "Proteus mirabilis"
    ],
    "Specimen Type(s)": [
        "Perirectal swabs",
        "Fresh stool",
        "Fecal specimens"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Selective and differential growth medium",
        "Chromogenic medium",
        "Manual visual interpretation"
    ],
    "Methodologies": [
        "Culture",
        "Chromogenic substrate detection"
    ],
    "Submission Type(s)": [
        "Medium",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Remel Spectra ESBL selective chromogenic medium for detection and presumptive identification of ESBL-producing bacteria from fecal and perirectal swab specimens.",
    "Indications for Use Summary": "Selective and differential medium for primary isolation and presumptive identification of ESBL-producing E. coli, K. pneumoniae, K. oxytoca, and P. mirabilis to aid in prevention and control in healthcare settings; not for diagnosis or treatment monitoring.",
    "fda_folder": "Microbiology"
}